Holly May
Corporate Officer/Principal presso BIOLINERX LTD.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Holly W.
May is currently the President-BioLineRx USA at BioLineRx Ltd.
She previously worked as the Vice President-Sales & Marketing at Swedish Orphan Biovitrum AB from 2018 to 2019.
Before that, she held positions as the Chief Commercial Officer at Avrobio, Inc., Vice President & Head-Commercial at Sobi, Inc., Vice President at Genzyme Israel Ltd., and Head-Marketing Operations at Sanofi-Aventis Israël Ltd.
Ms. May holds an MBA from the University of Akron and an undergraduate degree from the University of Miami.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOLINERX LTD.
-.--% | 15/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Holly May
| Società | Posizione | Inizio |
|---|---|---|
| BIOLINERX LTD. | Corporate Officer/Principal | 16/06/2022 |
Precedenti posizioni note di Holly May
| Società | Posizione | Fine |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Sales & Marketing | 01/08/2019 |
| Sanofi-Aventis Israël Ltd. | Sales & Marketing | - |
| Genzyme Israel Ltd. | Corporate Officer/Principal | - |
| Sobi, Inc. | Corporate Officer/Principal | - |
| AVROBIO, INC. | Corporate Officer/Principal | - |
Formazione di Holly May
| University of Akron | Masters Business Admin |
| University of Miami | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| BioLineRx Ltd. | |
| Sanofi-Aventis Israël Ltd. | |
| Sobi, Inc. | |
| Genzyme Israel Ltd. |
- Borsa valori
- Insiders
- Holly May
